Acreage Holdings Reports First Quarter 2022 Financial Results

9.2 min readPublished On: May 6th, 2022By

NEW YORK – Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U), (OTCQX: ACRHF, ACRDF), a multi-state operator of cannabis cultivation and retailing facilities in the U.S., today reported its financial results for the first quarter ended March 31, 2022.

First Quarter 2022 Financial Highlights

  • Consolidated revenue was $56.9 million for Q1 2022, an increase of 48% year-over-year.
  • Gross margin of 52% compared to 48% in Q4 2021, and 54% in Q1 2021.
  • Adjusted EBITDA* was $8.6 million in Q1 2022, compared to $1.6 million in Q1 2021. Adjusted EBITDA* as a percentage of consolidated revenue was 15.2% for the first quarter of 2022.

First Quarter 2022 Operational Highlights

  • Expanded the Company’s premier brand portfolio with the launch of Superflux, currently available in dispensaries across Illinois, Massachusetts, and Ohio. Superflux is a premium brand focused on honoring the cannabis craft, with each step of the development process designed to preserve the essence of cannabis in all its product forms: flower, live resin vapes, and concentrates.
  • Enhanced customer selection and experience by introducing a variety of new and innovative products under The Botanist brand in select markets.
  • Completed a licensing agreement with botanica to manufacture and distribute Mr. Moxey’s top-selling and award-winning THC mints in Acreage’s operating markets as regulations allow, including Ohio, New Jersey, Pennsylvania, Illinois, New York, and Maine.
  • Strengthened the senior leadership team with the appointment of Dennis Curran as the Company’s Chief Operating Officer and the addition of Steven Strom to its Board of Directors.

Subsequent Events

  • Commenced adult-use operations in New Jersey as part of an inaugural group of cannabis operators permitted to launch adult-use sales in the state. Acreage’s products, including its flagship brand The Botanist, are now available for adult-use consumers at its Egg Harbor Township and Williamstown dispensaries in southern New Jersey.
  • Closed the sale of the Company’s cultivation and processing facility in Medford, Oregon for total consideration of $2.0 million, and closed its dispensary in Powell, Oregon.
  • Completed the consolidation and conversion of its dispensary in Brewer, Maine to adult-use.
  • Appointed Corey Sheahan as General Counsel.

Management Commentary

“In the first quarter of 2022, we achieved our fifth consecutive quarter of positive Adjusted EBITDA and sequentially improved our gross margin, while continuing to grow revenue despite industry headwinds and pandemic related challenges in Q1,” said Peter Caldini, CEO of Acreage. “We remain focused and committed to delivering against our strategic priorities of accelerating our growth in our core markets, driving profitability, and strengthening our balance sheet.”

Mr. Caldini continued, “Operationally, we have worked to enhance our product offerings, including our newly launched craft brand Superflux and the recent rollout of a variety of innovative products under The Botanist brand across our footprint. This targeted approach to bringing consumers the premium products they are looking for in each of our markets has enabled us to maintain a top position in many of our core states.”

Mr. Caldini concluded, “Following the end of the quarter we were thrilled to begin adult-use sales in New Jersey. We are well-prepared for this market having recently completed the expansion of our Egg Harbor facility in anticipation of adult-use sales beginning this year. We have had a very successful launch and are looking forward to leveraging our expertise from New Jersey as we prepare for pending adult-use sales in New York and Connecticut. 2022 has started on strong footing for us and we remain committed to further delivering shareholder value as we execute on the significant growth opportunities ahead.”

Q1 2022 Financial Summary
(in thousands)

Three Months Ended March 31, YoY%
Change

Three Months
Ended Dec. 31,
2021

QoQ%
Change
2022 2021
Consolidated Revenue $ 56,879 $ 38,393 48 % $ 58,098 (2 )%
Gross Profit 29,510 20,621 43 % 27,583 7 %
% of revenue 52 % 54 % 48 %
Total operating expenses 32,232 18,815 71 % 63,210 (49 )%
Net loss (13,911 ) (8,642 ) (35,627 )
Net loss attributable to Acreage (12,694 ) (7,809 ) (40,351 )
Adjusted EBITDA* 8,627 1,595 8,459

Total revenue for Q1 2022 was $56.9 million, an increase of $18.5 million or 48% compared to Q1 2021. The year-over-year growth was primarily driven by the acquisitions of Ohio, California, and Maine operations over the past 12 months, which was somewhat offset by revenue declines due to the divestiture of Florida operations in April 2021 and declines within the Company’s operations that are being held for sale. Additionally, total revenue for Q1 2022 declined sequentially by $1.2 million or 2% compared to the fourth quarter. Excluding the Company’s California and Oregon operations which are not considered core, however, revenue for the three months ended March 31, 2022, increased slightly by 0.5% on a sequential basis as the Company was able to overcome challenges associated with the pandemic and industry pricing pressures which negatively impacted revenues.

Total gross profit for Q1 2022 was $29.5 million, an increase of $8.9 million or 43% compared to Q1 2021. Growth in revenue and efficiencies achieved at Acreage’s production facilities drove the increase in gross profit. Total gross margin was 52% in Q1 2022 compared to 54% in the first quarter of 2021. Excluding other revenue which has no associated costs of goods sold and which included non-recurring revenue in the prior comparable period, gross margin improved from 50% for the three months ended March 31, 2021, to 52% for the three months ended March 31, 2022.

Total operating expenses for Q1 2022 increased by $13.4 million, or 71% to $32.2 million, from Q1 2021. Excluding equity-based compensation expenses, losses, write-downs and recoveries, impairments, and depreciation and amortization expenses, all of which are non-cash in nature, total operating expenses for the three months ended March 31, 2022, increased $3.6 million or 19% compared to the corresponding period of fiscal 2021. The rate of increase in operating expenditures was significantly lower than the rate of increase in revenues and is due to Acreage’s expanded operations through growth and acquisitions.

Adjusted EBITDA* for the first quarter of 2022 increased to $8.6 million, compared to Adjusted EBITDA* of $1.6 million in the first quarter of 2021 and a slight improvement from Adjusted EBITDA* of $8.5 million in the fourth quarter of 2021. Adjusted EBITDA from core operations*, which excludes markets where Acreage has entered into definitive agreements to exit and start-up ventures such as beverages and CBD, was $9.3 million, indicating the Company’s core markets are still being negatively impacted by its non-core operations. Consolidated EBITDA* for the first quarter of 2022 was $1.3 million, compared to a consolidated EBITDA* of $1.6 million in the previous year’s comparable period.

Net loss attributable to Acreage for Q1 2022 was $(12.7) million, compared to $(7.8) million in the first quarter of 2021.

Balance Sheet and Liquidity

Acreage ended the quarter with $32.6 million in cash and cash equivalents. During Q4 2021, the Company secured a $150.0 million Credit Facility with a syndicate of lenders. Under the terms of the Credit Facility, $100.0 million was available for immediate use and a further $50.0 million is available in future periods under a committed accordion option once certain, predetermined milestones are achieved. Acreage intends to use the proceeds of the Credit Facility to fund expansion initiatives, repay existing debt, and provide additional working capital. As of March 31, 2022, $75.0 million was drawn under this facility. The remaining current availability under this facility of $25.0 million, together with cash and cash equivalents and restricted cash on hand of $32.6 million, provides funding of $57.6 million until December 31, 2022, at which time the Company expects the $50.0 million committed accordion to also be available.

Forward Looking Statements

This news release and each of the documents referred to herein contains “forward-looking information” and ‎‎“forward-looking statements” within the meaning of applicable Canadian and United States securities legislation, ‎respectively. All statements, other than statements of historical fact, included herein are forward-looking ‎information. ‎Often, but not always, forward-looking statements and information can be identified by the use of words such as ‎‎“plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, ‎or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, ‎‎‎“would”, “might” or “will” be taken, occur or be achieved. ‎

Forward-looking statements or information involve known and unknown risks, uncertainties, and other ‎factors which may cause the actual results, performance or achievements of Acreage or its ‎subsidiaries to be materially different from any future results, performance or achievements expressed or ‎implied by the forward-looking statements or information contained in this news release. Risks, uncertainties and other factors involved with forward-looking ‎information could cause actual events, results, performance, prospects and opportunities to differ ‎materially from those expressed or implied by such forward-looking information, including, but not ‎limited to financing and liquidity risks, and the risks disclosed in the Company’s Annual Report on Form 10-K for the year ended ‎December 31, 2021, ‎dated March 11, 2022 and the Company’s other public filings, in each case filed with the SEC on the EDGAR website at www.sec.gov and with ‎Canadian securities regulators ‎and available on the issuer profile of Acreage on SEDAR at www.sedar.com. Although Acreage has attempted to identify ‎important factors that could cause actual results to differ materially from those contained in forward-looking ‎information, there may be other factors that cause results not to be as anticipated, estimated or intended. ‎

Although Acreage believes that the ‎assumptions and factors used in preparing the forward-looking information or forward-looking ‎statements in this news release are reasonable, undue reliance should not be placed on such information ‎and no assurance can be given that such events will occur in the disclosed time frames or at all. The ‎forward-looking information and forward-looking statements included in this news release are made as of ‎the date of this news release and Acreage does not undertake any obligation to publicly update such ‎forward-looking information or forward-looking statements to reflect new information, subsequent events ‎or otherwise unless required by applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Service Provider has reviewed and does not accept ‎responsibility for the adequacy or accuracy of the content of this news release.‎

*NON-GAAP MEASURES, RECONCILIATION AND DISCUSSION (UNAUDITED)

This release includes Adjusted EBITDA, which is a non-GAAP performance measure that we use to supplement our results presented in accordance with U.S. GAAP. The Company uses Adjusted EBITDA to evaluate its actual operating performance and for planning and forecasting future periods. The Company believes that the adjusted results presented provide relevant and useful information for investors because they clarify the Company’s actual operating performance, make it easier to compare our results with those of other companies and allow investors to review performance in the same way as our management. Since these measures are not calculated in accordance with U.S. GAAP, they should not be considered in isolation of, or as a substitute for, net loss or our other reported results of operations as reported under U.S. GAAP as indicators of our performance, and they may not be comparable to similarly named measures from other companies.

The Company defines Adjusted EBITDA as net income before interest, income taxes and, depreciation and amortization and excluding the following: (i) income from investments, net (the majority of the Company’s investment income relates to remeasurement to fair value of previously-held interests in connection with our roll-up of affiliates, and the Company expects income from investments to be a non-recurring item as its legacy investment holdings diminish), (ii) equity-based compensation expense, (iii) non-cash impairment losses, (iv) transaction costs and (v) other non-recurring expenses (other expenses and income not expected to recur).

(This information is primarily sourced from Acreage Holdings, Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: News Team

Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!

Latest News

  • Medical Marijuana Market

Global Medical Marijuana Market Report 2022-2030

October 3rd, 2022|

Dublin - The global medical marijuana market size is expected to reach USD 65.8 billion by 2030 and is expected to expand at a CAGR of 21.6% The major factors attributed to the industry growth ...